• No results found

Sera and Vaccine

Opsonophagocidal Activity in Sera From Infants and Children Immunized With Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate)

Opsonophagocidal Activity in Sera From Infants and Children Immunized With Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate)

... seria meningitidis group B.’2 The latter approach has yielded a vaccine that elicits a good antibody response after a single 15-ag dose of vaccine in infants as young as 2 months of age,[r] ...

6

PIIS2211124718315699.pdf

PIIS2211124718315699.pdf

... There are four distinct DENV serotypes, and within DENV4, there are five distinct genotypes. The impact of genotypic diversity is not known, nor is it clear whether infection with one DENV4 genotype results in protective ...

11

First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

... Core of amino acid sequence of antigenic site bound by antibodies in neutralizing sera from dogs vaccinated with the synthetic vaccine and from previously described 27 naturally infected[r] ...

8

A Novel, Killed-Virus Nasal Vaccinia Virus Vaccine

A Novel, Killed-Virus Nasal Vaccinia Virus Vaccine

... In contrast to these results, protective immunity has been reported not to be achieved with several other formulations of live or inactivated VV. i.n. application of formalin-killed VV, either with or without NE, ...

11

Presumptive identification of Vibrio species with H antiserum

Presumptive identification of Vibrio species with H antiserum

... To ascertain the spectrum and level of cross-reaction that each of the seven anti-H sera displayed, they were each tested by H agglutination against the homologous vaccine strain, the si[r] ...

8

Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine

Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine

... trivalent sera, using biolayer ...Trivalent vaccine sera bind linear EBOV GP peptides similarly to single-component vaccine ...sera. Sera from animals vaccinated with either ...

24

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses

... Pre-vaccination sera were analysed by VP7 indirect ELISA at the Onderstepoort Veterinary Research Institute (ARC-OVI) in Pretoria, South Africa to determine prior exposure of the horses to AHS, either by ...

6

Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine

Multiepitopic B- and T-Cell Responses Induced in Humans by a Human Immunodeficiency Virus Type 1 Lipopeptide Vaccine

... the vaccine, as well as the corresponding ...the vaccine to induce IgG specific to Nef protein could be significant, since the HIV-1 Nef antigen can be present on the surface of in- fected cells, allowing ...

10

A Triclade DNA Vaccine Designed on the Basis of a Comprehensive Serologic Study Elicits Neutralizing Antibody Responses against All Clades and Subclades of Highly Pathogenic Avian Influenza H5N1 Viruses

A Triclade DNA Vaccine Designed on the Basis of a Comprehensive Serologic Study Elicits Neutralizing Antibody Responses against All Clades and Subclades of Highly Pathogenic Avian Influenza H5N1 Viruses

... Because of their rapid evolution, genetic diversity, broad host range, ongoing circulation in birds, and potential human-to-hu- man transmission, H5N1 influenza viruses remain a major global health concern. Their high ...

9

Predicted coverage and immuno-safety of a recombinant C-repeat region based Streptococcus pyogenes vaccine candidate

Predicted coverage and immuno-safety of a recombinant C-repeat region based Streptococcus pyogenes vaccine candidate

... a vaccine candidate we used this model to investigate whether SV1 deliv- ered in the presence of alum, a human approved adjuvant induced autoimmune inflammatory responses similar to that observed with ...in ...

17

Tick-borne Encephalitis Virus Vaccines Contain Non-structural Protein 1 (NS1) Antigen and May Elicit NS1-Specific Antibody Responses in Vaccinated Individuals

Tick-borne Encephalitis Virus Vaccines Contain Non-structural Protein 1 (NS1) Antigen and May Elicit NS1-Specific Antibody Responses in Vaccinated Individuals

... Encepur vaccine contains not only proteins of the whole virus particle, but also viral non-structural protein 1 ...IMMUN vaccine failed due to the high content of human serum albumin used as a stabilizer in ...

13

Evaluation of the Antigenic Relationships among Canine Parvovirus Type 2 Variants

Evaluation of the Antigenic Relationships among Canine Parvovirus Type 2 Variants

... The antigenic relationships among the original canine parvovirus type 2 (CPV-2) and the variants CPV-2a, -2b, and -2c were evaluated. Cross-antigenic evaluation revealed clear differences among the CPV variants, which ...

6

A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model

A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model

... adjuvanted vaccine demonstrated significantly better survival than Fc ␥ KO mice receiving 1 dose of adjuvanted vaccine ...prechallenge sera from these mice (day ⫺ ...the vaccine, serology ...

22

Immune response to type III group B streptococcal polysaccharide tetanus toxoid conjugate vaccine

Immune response to type III group B streptococcal polysaccharide tetanus toxoid conjugate vaccine

... (III-TT) vaccine at one of three doses; unconjugated GBS type III CPS; or ...In sera from recipients of the highest dose of III-TT, CPS-specific IgG levels rose from a geometric mean of ...conjugate ...

8

Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA

Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA

... of vaccine-induced Abs directed against a single region of the virus Env, the V3 loop, and showed that cross-clade NAbs were induced and that pseudoviruses that were not previously shown to be neutralized by ...

12

Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens

Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens

... in sera of ...the vaccine antigen, indicating that the future success of RiVax and other ricin toxin subunit vaccine antigens under inves- tigation, like RVEc, may depend on the identification of ...

9

Detection of antibodies to pneumococcal capsular polysaccharides by enzyme linked immunosorbent assay

Detection of antibodies to pneumococcal capsular polysaccharides by enzyme linked immunosorbent assay

... RESULTS The results of the determinations of total antibody to each of the 14 vaccine type PS antigens in prevaccination and 4 weeks postvaccination sera from 12 healthy adults and 6 pre[r] ...

7

Gallichotte_unc_0153D_18061.pdf

Gallichotte_unc_0153D_18061.pdf

... dengue vaccine has lower efficacy against DENV2 compared to the other 3 ...polyclonal sera to dissect the epitope-specific responses following primary DENV2 natural infection and monovalent ...

154

Radioimmunoassay for Quantitation of Antibodies to Alphaviruses with Staphylococcal Protein A

Radioimmunoassay for Quantitation of Antibodies to Alphaviruses with Staphylococcal Protein A

... In addition, sera from 73 individuals were screened for seroconversion following live attenuated Venezuelan equine encephalomyelitis virus vaccine strain TC-83 inoculation, by RIA using [r] ...

7

A Replication-Incompetent PB2-Knockout Influenza A Virus Vaccine Vector

A Replication-Incompetent PB2-Knockout Influenza A Virus Vaccine Vector

... antibodies. Sera from mice (3 mice per group) were obtained via mandibular vein bleeding prior to each immu- nization and via the femoral artery 1 day before ...the sera, nasal washes, and BAL fluid samples ...

6

Show all 10000 documents...

Related subjects